Sunitinib rechallenge in metastatic renal cell carcinoma patients - Abstract - UroToday PDF Print
UroToday
Sunitinib was a standard initial therapy in metastatic renal cell carcinoma (mRCC). Given the fact that many patients progressed through many available

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.